Blog

  • Meteorological satellites observe temperatures on Venus

    Meteorological satellites observe temperatures on Venus

    image: 

    A photo with magnified sections to show just how small Venus is in the field of view of the observation satellites. Despite this limitation, researchers can still gather useful data. ©2025 Nishiyama et al. CC-BY-ND


    view more 

    Credit: ©2025 Nishiyama et al. CC-BY-ND

    Imaging data from Japan’s Himawari-8 and -9 meteorological satellites have been successfully used to monitor temporal changes in Venus’ cloud-top temperature, revealing unseen patterns in the temperature structure of various waves. A team led by the University of Tokyo collated infrared images from 2015–25 to estimate brightness temperatures on day to year scales. The results demonstrate that meteorological satellites can serve as additional eyes to access the Venusian atmosphere from space and complement future observations from planetary missions and ground-based telescopes.

    The Himawari-8 and -9 satellites, launched in 2014 and 2016, respectively, were developed to monitor global atmospheric phenomena through use of their multispectral Advanced Himawari Imagers (AHIs). The University of Tokyo team led by visiting researcher Gaku Nishiyama saw the opportunity to use the cutting-edge sensor data for spaceborne observations of Venus, which is coincidentally captured by the AHIs near the Earth’s rim.

    Observing temporal temperature variations in the cloud tops of Venus is essential to understand its atmospheric dynamics and related phenomena, such as thermal tides and planetary-scale waves. Obtaining data for these phenomena presents multiple challenges, as Nishiyama explained. “The atmosphere of Venus has been known to exhibit year-scale variations in reflectance and wind speed; however, no planetary mission has succeeded in continuous observation for longer than 10 years due to their mission lifetimes,” he said. “Ground-based observations can also contribute to long-term monitoring, but their observations generally have limitations due to the Earth’s atmosphere and sunlight during the daytime.” 

    Meteorological satellites on the other hand appear suited to fill this gap with their longer mission lifetimes (the Himawari-8 and -9 satellites are scheduled for operation until 2029). The AHIs allow multiband infrared coverage, which has been limited in planetary missions to date, essential for retrieving temperature information from different altitudes, along with low-noise and frequent observation. Aiming to demonstrate this potential to contribute to Venus science, the team investigated the observed temporal dynamics of the Venusian atmosphere and provided a comparative analysis with previous datasets. “We believe this method will provide precious data for Venus science because there might not be any other spacecraft orbiting around Venus until the next planetary missions around 2030,” said Nishiyama.

    The team first established a data archive by extracting all Venus images from the collected AHI datasets, identifying 437 occurrences in total. Taking into account background noise and apparent size of Venus in the captured images, they were able to track the temporal variation in cloud-top temperature during the periods where the geostationary satellite, Venus and the Earth lined up in a row.

    The retrieved temporal variations in brightness temperatures were then analyzed on both year and day scales and compared for all infrared bands to investigate variability of thermal tides and planetary-scale waves. Variation in thermal tide amplitude was confirmed from the obtained dataset. The results also confirmed change in amplitude of planetary waves in the atmosphere with time, appearing to decrease with altitude. While definitive conclusions on the physics behind the detected variations were challenging due to the limited temporal resolution of the AHI data, variations in the thermal tide amplitude appeared possibly linked to decadal variation in the Venus atmosphere structure.

    In addition to successfully applying the Himawari data to planetary observations, the team was further able to use the data to identify calibration discrepancies in data from previous planetary missions.

    Nishiyama is already looking at implications of the study beyond Venus’ horizon. “I think that our novel approach in this study successfully opened a new avenue for long-term and multiband monitoring of solar system bodies. This includes the moon and Mercury, which I also study at present. Their infrared spectra contain various information on physical and compositional properties of their surface, which are hints at how these rocky bodies have evolved until the present.” The prospect of accessing a range of geometric conditions untethered from the limitations of ground-based observations is clearly an exciting one. “We hope this study will enable us to assess physical and compositional properties, as well as atmospheric dynamics, and contribute to our further understanding of planetary evolution in general.”

    ###

    Journal article: Gaku Nishiyama, Yudai Suzuki, Shinsuke Uno, Shohei Aoki, Tatsuro Iwanaka, Takeshi Imamura, Yuka Fujii, Thomas G. Müller, Makoto Taguchi, Toru Kouyama, Océane Barraud, Mario D’Amore, Jörn Helbert, Solmaz Adeli, Harald Hiesinger, “Temporal variation in the cloud-top temperature of Venus revealed by meteorological satellites”, Earth, Planets and Space, DOI: 10.1186/s40623-025-02223-8

    Funding: This work was supported by JSPS KAKENHI Grant Number JP22K21344, 23H00150, and 23H01249, and JSPS Overseas Research Fellowship.

        
    Useful links:

    Department of Earth and Planetary Science – https://www.eps.s.u-tokyo.ac.jp/en/
    Graduate School of Science – https://www.s.u-tokyo.ac.jp/en/index.html

    Research contact:
    Dr. Gaku Nishiyama
    Department of Earth and Planetary Science, The University of Tokyo,
    7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
    gaku.nishiyama@dlr.de

    Press contact:
    Mr. Rohan Mehra
    Public Relations Group, The University of Tokyo,
    7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan
    press-releases.adm@gs.mail.u-tokyo.ac.jp
     

    About The University of Tokyo:

    The University of Tokyo is Japan’s leading university and one of the world’s top research universities. The vast research output of some 6,000 researchers is published in the world’s top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 5,000 international students. Find out more at www.u-tokyo.ac.jp/en/ or follow us on X (formerly Twitter) at @UTokyo_News_en.


    Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

    Continue Reading

  • Quantum Science Information | AZoQuantum.com

    Quantum Science Information | AZoQuantum.com

    While we only use edited and approved content for Azthena
    answers, it may on occasions provide incorrect responses.
    Please confirm any data provided with the related suppliers or
    authors. We do not provide medical advice, if you search for
    medical information you must always consult a medical
    professional before acting on any information provided.

    Your questions, but not your email details will be shared with
    OpenAI and retained for 30 days in accordance with their
    privacy principles.

    Please do not ask questions that use sensitive or confidential
    information.

    Read the full Terms & Conditions.

    Continue Reading

  • Affordability a ‘formidable challenge’ as load shifts to tech, industrial customers: ICF

    Affordability a ‘formidable challenge’ as load shifts to tech, industrial customers: ICF

    Dive Brief:

    • Keeping electricity affordable for consumers is a “formidable challenge” amid projections of declining generation capacity reserves and persistent uncertainty around the scale and pace of future load growth, ICF International Vice President of Energy Markets Maria Scheller said Thursday. 
    • Meanwhile, broad policy uncertainty and an increasingly shaky regulatory environment give utilities and capital markets pause about expensive new infrastructure investments that could become stranded assets, Scheller said in a webinar on ICF’s “Powering the Future: Addressing Surging U.S. Electricity Demand” report.
    • Policy conversations around import tariffs, federal energy tax credits and permitting reform are unfolding as the balance of electricity demand shifts from residential and business consumers to technology and industrial customers, which tend to require around-the-clock power, Scheller added.

    Dive Insight:

    The coming shift in U.S. electricity consumption represents less of a new paradigm than a return to the industrial-driven demand the country saw from the 1950s into the 1980s, after which deindustrialization and consumer-centric trends like the widespread adoption of air conditioning, electric resistance heating and personal computing shifted the balance toward the residential segment, Scheller said.

    The shift is important because unlike residential loads, which show considerable seasonal and intraday variation, industrial loads are flatter, less weather-dependent and more sensitive to voltage fluctuations, Scheller said.

    By 2035, ICF expects nearly 40% of total U.S. load will have a “flat, power-quality-sensitive profile,” and that overall load will grow faster than peak load, she said. In 2030, ICF projects more than 3% annual power consumption growth, compared with less than 2% annual peak load growth, according to a webinar slide.

    That’s not to say residential demand won’t also grow in the next few years as consumers electrify home heating and buy more electric vehicles — only that data centers and other industrial demand will “dwarf” it, Scheller said.

    The only significant regional exception to that expectation is California, where ICF says light- and heavy-duty transportation electrification will drive most load growth through 2040. 

    Capacity reserves will quickly dwindle across most of the United States as a result of near-term load growth, regardless of the regional drivers, said Lalit Batra, ICF director of energy markets.

    “We expect the capacity reserve across most regions to be absorbed in the next few years,” Batra said.

    ICF sees nationwide capacity reserves — currently between 20% and 25% — below the 15% target reserve margin by 2030 and in negative territory by 2035, according to a webinar slide. Without a meaningful acceleration in new generation deployment, some combination of delayed power plant retirements, load flexibility or slower overall load growth will be needed to avoid shortages, Batra said.

    Building new power plants fast enough to keep pace with load growth will be more difficult if Republicans in Congress effectively repeal the Inflation Reduction Act, according to ICF’s projections. If the final budget reconciliation bill preserves the rapid phaseout of clean energy tax credits in the version the U.S. House of Representatives passed in May, ICF projects the U.S. would deploy 280 GW fewer renewables and storage capacity and 43 GW more gas and nuclear through 2040, even as cost-competitiveness, supportive state policy and corporate power buyers’ preference for clean electricity supports robust regional markets for those technologies. 

    Regardless of the policy scenario, ICF expects electricity prices to rise as much as 25% in some regions through 2030 due to necessary grid expansion, wildfire hardening and other infrastructure projects, along with gas price volatility, said Deb Harris, ICF vice president for climate change and sustainability. ICF expects U.S. gas prices to be 7% higher in 2035 and 17% higher in 2045 if the House budget becomes law relative to a status-quo scenario, according to a webinar slide.

    Utilities and regulators already have the tools to mitigate some of these changes, Harris said. For example, demand response programs and flexible load interconnection could avoid about 30% of infrastructure investment costs that would otherwise be necessary, Harris said. Large loads are more open than some realize to ramping down load or investing in more efficient processes, such as liquid rather than air cooling of server racks, she added.

    “These large load customers do offer a lot of opportunities” for efficiency and demand response, she said. “Energy is the number one [operating] cost they face.”

    Permitting reforms like uniform siting standards, incentives for brownfield redevelopment and wider adoption of advanced GIS tools to locate “areas of minimal impact” for energy development could speed up new builds and keep prices in check, Harris added.

    The catch, she said, is that while efforts to mitigate rising electricity prices may benefit customers and the politicians who represent them, project developers and their lenders and investors want to see durable price signals before committing to build new generation and transmission.

    Continue Reading

  • Vectorized Antibodies Market Research Report 2025-2034 |

    Vectorized Antibodies Market Research Report 2025-2034 |

    Dublin, June 30, 2025 (GLOBE NEWSWIRE) — The “Vectorized Antibodies Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges” has been added to ResearchAndMarkets.com’s offering.

    The Global Vectorized Antibodies Market, valued at USD 9.49 billion in 2025, is poised for robust growth, anticipated to expand at a significant CAGR of 7.7% to reach USD 15.94 billion by 2034.

    This market is at the cutting edge of biotherapeutics, employing gene therapy techniques to deliver antibody coding sequences directly into the body via viral or non-viral vectors. This novel approach reduces the need for frequent dosing of protein-based drugs, fostering prolonged in vivo production of therapeutic antibodies with the potential for prolonged efficacy and streamlined manufacturing processes.

    This innovation holds substantial promise for chronic conditions such as HIV, cancer, autoimmune disorders, and rare genetic diseases, where continuous antibody presence is crucial. By merging genetic engineering precision with antibody targeting specificity, vectorized antibodies aim to enhance therapeutic outcomes and patient adherence.

    As clinical trials continue demonstrating safety and efficacy, the vectorized antibodies market may redefine the landscape of biologic therapies. Manufacturing scalability and batch consistency are critical hurdles, but advances in vector production infrastructure support continued progress. The regulatory landscape is evolving, particularly in classifying gene therapies and combination products.

    The report provides comprehensive insights into the vectorized antibodies market, covering market size and growth projections, trends, challenges, competitive landscape, and regional analyses across North America, Europe, Asia-Pacific, Middle East and Africa, and South and Central America. It’s an invaluable resource for top management, investors, and stakeholders to strategize and capitalize on emerging opportunities.

    Customization options are available, with up to 10% free customization (up to 10 analyst hours) offered to modify segments, geographies, and analyzed companies. Post-sale support includes four analyst hours, available for up to four weeks, delivered in the latest PDF and Excel formats.

    Key Market Insights:

    • Vectorized antibodies reduce the need for repeated dosing, potentially lowering long-term treatment costs and healthcare burdens.
    • North America’s leadership is due to its advanced gene therapy infrastructure and supportive funding landscape, while Europe progresses with regulatory and collaborative support.
    • The focus is on enhancing vector payload capacity and specificity while minimizing immunogenic responses.
    • Applications range across oncology, infectious, autoimmune, and rare genetic diseases.
    • Key challenges include vector delivery efficacy, long-term safety considerations, and regulatory complexities.
    • North America: Leads the market, driven by investments in gene therapy research and a dynamic biotech ecosystem. Strategic collaborations between academia and industry further bolster growth.
    • Europe: Experiences steady growth, supported by regulatory frameworks that encourage advanced therapy medicinal products. Key players focus on optimizing vector delivery, reducing immunogenicity, and scaling production under GMP conditions.
    • While the market is in its early stages, it is advancing rapidly with numerous partnerships, licensing agreements, and venture capital inflows driving clinical pipeline development.

    Key Attributes:

    Report Attribute Details
    No. of Pages 150
    Forecast Period 2025 – 2034
    Estimated Market Value (USD) in 2025 $9.49 Billion
    Forecasted Market Value (USD) by 2034 $18.5 Billion
    Compound Annual Growth Rate 7.7%
    Regions Covered Global

    Companies Featured

    • Adagio Therapeutics
    • ReiThera Srl
    • Voyager Therapeutics
    • Spark Therapeutics
    • Freeline Therapeutics
    • BioNTech SE
    • Moderna, Inc.
    • AskBio (subsidiary of Bayer AG)
    • Genethon
    • Vector BioPharma AG
    • Sangamo Therapeutics
    • Passage Bio
    • Gilead Sciences, Inc.
    • Vir Biotechnology, Inc.
    • Regeneron Pharmaceuticals, Inc.

    For more information about this report visit https://www.researchandmarkets.com/r/osx0kq

    About ResearchAndMarkets.com
    ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

    • Vectorized Antibodies Market
    
                

    Continue Reading

  • ‘Someone compared it to Bohemian Rhapsody’: Wookie on making UK garage classic Battle | Dance music

    ‘Someone compared it to Bohemian Rhapsody’: Wookie on making UK garage classic Battle | Dance music

    Wookie, producer

    People say Battle reminds them of some really good years for Britain as a country. We were entering a new millennium, everyone was running their own business, making money and the underground record industry was thriving. I wanted to do a UK garage version of Southern Freeez, by the 80s UK funk band Freeez. Initially, Battle was going to be another instrumental, and then Lain, the singer, came in the room and goes: “Let me put something on this.” I was like: “I’m not sure it’s really a vocal song.” But Lain stacked the vocals, and someone compared it to Queen’s Bohemian Rhapsody, with all the harmonies.

    At the time, some people believed that I had copied a dubplate by [UK garage figure] DJ EZ. It is similar – his bassline does something like that. But I know I didn’t copy him, because I didn’t go out that much! So I’d never really heard EZ at that stage.

    I didn’t know Battle was going to be as big as it was or have the impact it did – it was just another tune. Then it started to float around: a few DJs had it, the A&R people. Ears started to prick up. I think we added a level of sophistication to garage, even though people like MJ Cole and TJ Cases were already doing that. When we were trying to get Battle on the radio, one station said it was too intelligent for their listeners and they wouldn’t play it.

    Battle eventually reached No 10 in August 2000. Louise Redknapp got the No 9 spot by 2,000 copies. It allowed me to appear on a TV show that I had watched my whole life as I was growing up: Top of the Pops.

    A lot of people say: “Oh, garage is on the comeback.” But for me, it has been for the last 13 years. I started DJing in 2012 and every year I’m working. It’s been well received by a wider audience ever since, younger and younger.

    Lain, singer

    Jason Chue, AKA Wookie, was knocking about in jungle, drum’n’bass, trying to siphon off that whole energy and then putting songs to it. I remember him saying about Battle: “I’ve done something strange with the intro.” I was like: “No, just play it.” He was almost apologising for it – but it was like a godsend. That intro had such an urgency. It felt like it was piercing your soul. I said: “Give me a minute.” Then I walked out and I don’t even know if it was half an hour, but I came back and I had written all of the vocal. That’s divine. For the song title we wanted one word. There are a lot of three-word titles, but one word is strong. Whether it’s bringing up three kids on your own, or addiction, everyone’s battling through something, every day.

    People call Battle a gospel song. Back then I was doing a lot of regular R&B but I really wanted to do something that involved my faith. When Jazzie B [founder of Soul II Soul and mentor to Wookie] called me about working with Jason, I thought he was going to say: “No, we don’t want that.” But he said: “Just go for it.” We had all these record label bosses trying to sign Battle – one guy had a Maserati and he blew out his speakers playing it. Months later he said: “I didn’t realise I was blowing out my speakers to a gospel tune.”

    I first realised Battle was going to be big at [seminal UK garage night] Twice As Nice. Jason said: “You should come down to Twice As Nice because I think this tune’s going.” I was a bit worried because I don’t really go out. So they played the tune and everyone started going: “Booooo!” OK, that’s not a good sign. But Jason was like, “No, no, no – that means they really like it!”

    Battle has endured because of what it means to the person who hears it. Back then, we would do PAs and people would say: “That song – my mum was going through cancer and that helped me.” And, 25 years later, someone said: “While I was in prison, that song got me through.” That’s everyone. That’s anyone. I remember Jason sending me a picture of someone who tattooed the middle eight of Battle on her forearm: “I can always rely / On my faith to get by.”

    Wookie’s new single Back 2 Us (ft Kyno) is out now

    Continue Reading

  • Scientists just found a sugar switch that protects your brain from Alzheimer’s

    Scientists just found a sugar switch that protects your brain from Alzheimer’s

    A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle against Alzheimer’s disease and other forms of dementia: brain sugar metabolism. Published in Nature Metabolism, the research uncovers how breaking down glycogen — a stored form of glucose — in neurons may protect the brain from toxic protein buildup and degeneration.

    Glycogen is typically thought of as a reserve energy source stored in the liver and muscles. While small amounts also exist in the brain, particularly in support cells called astrocytes, its role in neurons has long been dismissed as negligible. “This new study challenges that view, and it does so with striking implications,” says Professor Pankaj Kapahi, PhD, senior scientist on the study. “Stored glycogen doesn’t just sit there in the brain; it is involved in pathology.”

    The research team, led by postdoc Sudipta Bar, PhD, discovered that in both fly and human models of tauopathy (a group of neurodegenerative diseases including Alzheimer’s), neurons accumulate excessive glycogen. More importantly, this buildup appears to contribute to disease progression. Bar says tau, the infamous protein that clumps into tangles in Alzheimer’s patients, appears to physically bind to glycogen, trapping it and preventing its breakdown.

    When glycogen can’t be broken down, the neurons lose an essential mechanism for managing oxidative stress, a key feature in aging and neurodegeneration. By restoring the activity of an enzyme called glycogen phosphorylase (GlyP) — which kicks off the process of glycogen breakdown — the researchers found they could reduce tau-related damage in fruit flies and human stem cell-derived neurons.

    Rather than using glycogen as a fuel for energy production, these enzyme-supported neurons rerouted the sugar molecules into the pentose phosphate pathway (PPP) — a critical route for generating NADPH (nicotinamide adenine dinucleotide phosphate) and Glutathione, molecules that protect against oxidative stress. “By increasing GlyP activity, the brain cells could better detoxify harmful reactive oxygen species, thereby reducing damage and even extending the lifespan of tauopathy model flies,” said Bar.

    Even more promising, the team demonstrated that dietary restriction (DR) — a well-known intervention to extend lifespan — naturally enhanced GlyP activity and improved tau-related outcomes in flies. They further mimicked these effects pharmacologically using a molecule called 8-Br-cAMP, showing that the benefits of DR might be reproduced through drug-based activation of this sugar-clearing system. “This work could explain why GLP-1 drugs, now widely used for weight loss, show promise against dementia, potentially by mimicking dietary restriction,” said Kapahi.

    Researchers also confirmed similar glycogen accumulation and protective effects of GlyP in human neurons derived from patients with frontotemporal dementia (FTD), strengthening the potential for translational therapies. Kapahi says the study emphasizes the power of the fly as a model system in uncovering how metabolic dysregulation impacts neurodegeneration. “Work in this simple animal allowed us to move into human neurons in a much more targeted way,” he said.

    Kapahi also acknowledges the Buck’s highly collaborative atmosphere as a major factor in the work. His lab, with expertise in fly aging and neurodegeneration, took advantage of proteomics expertise in the Schilling lab and the Seyfried lab (at Emory University) as well as the Ellerby lab which has expertise in human iPSCs and neurodegeneration.

    Kapahi says this study not only highlights glycogen metabolism as an unexpected hero in the brain but also opens up a new direction in the search for treatments against Alzheimer’s and related diseases. “By discovering how neurons manage sugar, we may have unearthed a novel therapeutic strategy: one that targets the cell’s inner chemistry to fight age-related decline,” he says. “As we continue to age as a society, findings like these offer hope that better understanding — and perhaps rebalancing — our brain’s hidden sugar code could unlock powerful tools for combating dementia.”

    Coauthors: Additional Buck collaborators include Kenneth A. Wilson, Tyler A.U. Hilsabeck, Sydney Alderfer, Jordan B Burton, Samah Shah, Anja Holtz, Enrique M. Carrera, Jennifer N. Beck, Jackson H Chen, Grant Kauwe, Tara E. Tracy, Birgit Schilling, and Lisa M. Ellerby. Other collaborators include Eric B. Dammer, Fatemeh Seifar and Nicholas T. Seyfried, Emory Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA as well as Ananth Shantaraman, Department of Biochemistry, Emory University School of Medicine, Atlanta, GA

    Acknowledgments: The work was supported by NIH grants R01AG038688, R21AG054121, AG045835, R01AG071995, R01AG070193, T32AG000266-23, R01AG061879, P01AG066591 and 1S10 OD016281. Other support came from the Hevolution Foundation, American Federation of Aging Research, the Larry L. Hillblom Foundation and the CatalystX award from Alex and Bob Griswold

    Continue Reading

  • The Vivienne died from cardio-respiratory arrest due to ketamine use, inquest finds | Drugs

    The Vivienne died from cardio-respiratory arrest due to ketamine use, inquest finds | Drugs

    The drag artist known as The Vivienne died from misadventure after suffering cardio-respiratory arrest after taking ketamine, a coroner has ruled.

    James Lee Williams, 32, was found in the bath by a neighbour at their home in Chorlton-by-Backford, Cheshire, on Sunday 5 January. The last time anyone had contact with them was two days earlier, a court was told, when a friend said it was evident the entertainer had taken ketamine.

    Five drug snap bags were found in The Vivienne’s property, including in a bedroom drawer and a bin in the bathroom, an inquest at Warrington coroner’s court heard on Monday.

    Although the performer had struggled with drugs in the past, Williams’s family told the hearing they should not be remembered for their use of ketamine and that drugs did not define the person they were.

    Friends and family had no worries about Williams’s mental health, the hearing was told, and the performer was looking forward to future roles on TV and in the theatre, although did “occasionally” take ketamine.

    Jacqueline Devonish, the senior coroner for Cheshire, concluding the inquest, said: “The medical cause of death is cardio-respiratory arrest due to ketamine use. The conclusion, on the balance of probabilities, is that I’m satisfied that James Williams’s death was a misadventure, he took ketamine but he did not intend to take his own life.”

    A report from a toxicologist, Dr Kerry Taylor, said tests showed a relatively high level of ketamine, but not at a level normally causing death. However, the drug can cause drowsiness, seizures and heart stimulation, and the concentration may have dissipated over time.

    Williams was the winner of the first series of RuPaul’s Drag Race UK and years later spoke about having been a drug addict. In April, their sister, Chanel Williams, questioned whether the “stigma” surrounding drug use had prevented them from seeking help.

    She told the BBC Two current affairs programme Newsnight that The Vivienne did not discuss their relapse, including a hospital stay, to “protect” their family, after a “really long period of sobriety”.

    “It’s hard for me because I think, if that stigma wasn’t there, would my brother have sought the help he needed?” she said. “To think that, if we’d known, or if he’d have felt able to talk and really reach out for the help that was needed, the outcome could’ve been different. That’s why we’ve shared James’s story.”

    Williams’s family have said they would work with the drug charity Adferiad on future campaigns. Their sister has called for ketamine to become a class A drug rather than class B, because people “think it’s less harmful than other drugs”.

    The government is seeking expert advice as the illegal use of ketamine has surged to record levels.

    Continue Reading

  • 4.8-magnitude earthquake jolts parts of Balochistan – Samaa TV

    1. 4.8-magnitude earthquake jolts parts of Balochistan  Samaa TV
    2. No casualties reported as 5.3-magnitude quake hits Balochistan  Dawn
    3. 5.2 magnitude earthquake hits Pakistan  Times of India
    4. Earthquake Today: 5.5 magnitude quake hits Pakistan, 3 people injured in third quake within 24 hours  Mint
    5. Earthquake of magnitude 5.3 jolts central Pakistan  Hindustan Times

    Continue Reading

  • Media accreditation open for New Delhi 2025 World Para Athletics Championships

    The media accreditation system for the New Delhi 2025 World Para Athletics Championships is now open.

    International Media is invited to apply for accreditation clicking here. The accreditation period for Indian-based media and photographers will be open at a later stage.

    The deadline to apply for international media accreditation is 25 July 2025.

    Available categories for media accreditation are as per below: 

    •    Press 
    •    Photographer 
    •    Rights-holding Broadcasters 
    •    Non-rights-holding TV and Radio Broadcaster 
     
    Professionals will be contacted about their accreditation status after this date. Completion of the registration process does not automatically guarantee accreditation. 

    Please note that nationals from certain countries may require a short-term stay visa to enter India. For more information and to confirm if you come from a country or region that requires a visa to enter India visit https://india-evisa.it.com.

    If you have any questions, please contact media@WorldParaAthletics.org.


    Continue Reading

  • Tsitsipas retires due to back injury, French qualifier Royer advances – ATP Tour

    1. Tsitsipas retires due to back injury, French qualifier Royer advances  ATP Tour
    2. Former Grand Slam finalist and one half of tennis power couple looks devastated at he retires at Wimbledon  The Sun
    3. Tsitsipas falls in the first round due to physical problems  Punto de Break
    4. Stefanos Tsitsipas calls physio and retires from Wimbledon to hand world No.113 first win  Daily Express

    Continue Reading